Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Fat stem cells from diabetic mice can still help heal wounds.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Whale genes show changes that help them live in water, like less hair and better flippers.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

COVID-19 may harm male fertility and damage the reproductive system.

Hair follicle regeneration may slow tumor growth.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Hair in mammals likely evolved from glandular structures, not scales.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Sonicated platelet-rich plasma boosts hair growth by activating stem cells.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.